Towards an HIV Cure
AIM: To drive concerted efforts to accelerate global scientific research, advocacy and collaboration towards a cure for HIV
"It is time to more firmly plant the need for an HIV cure on the policy agenda. While interventions that lead to a meaningful cure are at least decades away, we must begin planning for it sooner than later. Once available, we must ensure a cure can be successfully delivered to those countries most burdened by the disease, and delivery must come at speed."
Sharon Lewin
With support from:
Towards an HIV Cure Advisory Board
Towards an HIV Cure Advisory Board
-
Charu Kaushic, Canadian Institute of Health Research (CIHR), Canada
-
Diana Finzi, NIAID/NIH, United States
-
Florence Thune, Sidaction, France
-
Glaudina Loots, Department of Science & Technology, South Africa
-
Glenda Gray, South African Medical Research Council, South Africa
-
Maureen Goodenow, NIH-OAR, United States
-
Remko van Leeuwen, Aidsfonds, The Netherlands
-
Meg Doherty, WHO, Switzerland
-
Michaela Müller-Trutwin, ANRS and Institut Pasteur, France
-
Mike McCune, Bill & Melinda Gates Foundation, United States
-
Mitchell Warren, AVAC, United States
-
Moses Supercharger Nsubuga, Stigmaless, Uganda
-
Peter Godfrey-Faussett, UNAIDS, Switzerland
-
Richard Jefferys, Treatment Action Group (TAG), United States
-
Rowena Johnston, amfAR, United States
-
Sharon Lewin, The Doherty Institute, University of Melbourne, Australia
-
Steve Deeks, UCSF, United States
-
Thumbi Ndung'u, University of KwaZulu-Natal and AHRI, South Africa
-
Yiming Shao, CDC, China